Philippe Langella

<i>Faecalibacterium prausnitzii</i> is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

Harry Sokol, Bénédicte Pigneur, Laurie Watterlot et al. · Proceedings of the National Academy of Sciences · 2008 · 4.2K citations · Full text

Dysbiosis, Immunology, Gastroenterology +18

CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands

Bruno Lamas, Mathias L. Richard, Valentin Leducq et al. · Nature Medicine · 2016 · 1.4K citations · Full text

Inflammation, Dysbiosis, Mucosal Immunology +12

Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment

Jacques Amar, Chantal Chabo, Aurélie Waget et al. · EMBO Molecular Medicine · 2011 · 821 citations · Full text

Identification of an anti-inflammatory protein from <i>Faecalibacterium prausnitzii</i> , a commensal bacterium deficient in Crohn’s disease

Elodie Quévrain, Marie-Anne Maubert, Christophe Michon et al. · Gut · 2015 · 790 citations · Full text

Functional Characterization of Novel Faecalibacterium prausnitzii Strains Isolated from Healthy Volunteers: A Step Forward in the Use of F. prausnitzii as a Next-Generation Probiotic

Rebeca Martín, Sylvie Miquel, Leandro Benevides et al. · Frontiers in Microbiology · 2017 · 379 citations · Full text